MANAGEMENT TEAM
CEO:
Entrepreneur with a successful track record in pharmaceutical ventures, André Ulmann , MD, PhD has been CEO of Celogos since 2006. André is Chairman of the Supervisory Board of HRA Pharma, an emerging European pharmaceutical company that he founded in 1996, and an active board member of several innovative start-ups.
R&D Director:
Expert in Gene and Cell Therapies with an extensive experience in non clinical & clinical studies, Christelle DOUCET, PhD has been Head of Clinical Development in Cell Therapy for Celogos between 2006-2009. Christelle is now R&D Director.
Supervisory Board
Erin Gainer, Chairman
Henri Monod
Christelle DOUCET, PhD, R&D Director
Management Board
André Ulmann, Chief Executive Officer
Hélène Guillard
Luc Massart
André Ulmann, M.D, PhD, Chief Executive Officer
André Ulmann, the President and CEO of Celogos, is an expert in endocrinology and an experienced professional from the pharmaceutical industry. He worked for ten years as Assistant Professor at a Paris medical university before joining Roussel Uclaf in 1983, where he later became Medical Director. After the merger with Hoechst and subsequent reorganization he was nominated Head of Endocrinology and Immunology, overseeing all endocrinology R&D, a position he held until 1996 when he left to create HRA Pharma, a French pharmaceutical company. Following the 2005 alliance between HRA Pharma and Celogos, Dr. Ulmann became CEO of Celogos.
André Ulmann, the President and CEO of Celogos, is an expert in endocrinology and an experienced professional from the pharmaceutical industry. He worked for ten years as Assistant Professor at a Paris medical university before joining Roussel Uclaf in 1983, where he later became Medical Director. After the merger with Hoechst and subsequent reorganization he was nominated Head of Endocrinology and Immunology, overseeing all endocrinology R&D, a position he held until 1996 when he left to create HRA Pharma, a French pharmaceutical company. Following the 2005 alliance between HRA Pharma and Celogos, Dr. Ulmann became CEO of Celogos.